Viking Therapeutics stock price ended on $9.96 on Tuesday after gaining 4.18%

The Viking Therapeutics stock price gained 4.18% on the last trading day (Tuesday, 7th Feb 2023), rising from $9.56 to $9.96. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 6.28% from a day low at $9.37 to a day high of $9.96. The price has risen in 6 of the last 10 days and is up by 15.55% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 181 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $18.25 million.

Maxim Group is very positive about VKTX and gave it a "$10.00 - $15.00" rating on Dec 20, 2022. The price target was changed from 10 to 15.Over the last 90 days, this security got 1 buy, 0 sell, and 0 hold ratings.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled.Given the current short-term trend, the stock is expected to rise 133.09% during the next 3 months and, with a 90% probability hold a price between $18.45 and $28.60 at the end of this 3-month period.

Mostly positive signals in the chart today. The Viking Therapeutics stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $9.11 and $8.51. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, January 05, 2023, and so far it has risen 23.27%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

On the downside, the stock finds support just below today's level from accumulated volume at $8.45 and $8.09.There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Viking Therapeutics finds support just below today's level at $8.45. If this is broken, then the next support from accumulated volume will be at $8.09 and $7.89.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.589 between high and low, or 6.28%. For the last week, the stock has had daily average volatility of 6.63%.

Viking Therapeutics holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.